Page last updated: 2024-08-24

trovafloxacin and Bronchitis

trovafloxacin has been researched along with Bronchitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldwin, RJ; LĂ©ophonte, P; Pluck, N1
Daniel, R; O'Doherty, B1
Hopkins, S; Williams, D1

Trials

3 trial(s) available for trovafloxacin and Bronchitis

ArticleYear
Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chronic Disease; Drug Therapy, Combination; Female; Fluoroquinolones; Haemophilus Infections; Humans; Male; Middle Aged; Naphthyridines; Pneumococcal Infections

1998
Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Penicillins

1998
Safety of trovafloxacin in treatment of lower respiratory tract infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6

    Topics: Acute Disease; Aged; Anti-Infective Agents; Bronchitis; Cardiovascular System; Chronic Disease; Community-Acquired Infections; Digestive System; Double-Blind Method; Europe; Fluoroquinolones; Humans; Naphthyridines; Nervous System; Pneumonia, Bacterial

1998